Product
Nangibotide
Aliases
LR12
1 clinical trial
2 indications
Indication
ShockIndication
SepticemiaClinical trial
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock. A Randomized, Double-blind, Placebo Controlled Dose Selection StudyStatus: Active (not recruiting), Estimated PCD: 2022-05-09